ACT-GLOBAL IA Thrombolysis(ACT-REACT-004)Domain Within the ACT-GLOBAL Adaptive Platform Trial-NCT06352632

NCT07687056 · clinicaltrials.gov ↗

PHASE3

Phase

NOT_YET_RECRUITING

Status

1500

Enrollment

OTHER

Sponsor class

Conditions

Stroke, Acute Ischemic
Endovascular Thrombectomy
Acute Ischemic Stroke AIS

Interventions

BIOLOGICAL: Tenecteplase or Alteplase- depending upon availability at each treating centre
OTHER: Control

Sponsor

University of Calgary

Collaborators

[object Object]